
Tianjin Medical Journal ›› 2024, Vol. 52 ›› Issue (3): 250-255.doi: 10.11958/20231036
• Cell and Molecular Biology • Previous Articles Next Articles
XIANG Jinjie(
), LYU Maoxin, WANG Mengyue, ZHANG Kun, LI Hao△(
)
Received:2023-07-12
Revised:2023-09-02
Published:2024-03-15
Online:2024-03-13
Contact:
△E-mail: XIANG Jinjie, LYU Maoxin, WANG Mengyue, ZHANG Kun, LI Hao. Molecular mechanisms of Ca2+-induced pyroptosis and adhesion changes of HK-2 cells in the formation of calcium-containing kidney stones[J]. Tianjin Medical Journal, 2024, 52(3): 250-255.
CLC Number:
| 基因名称 | 引物序列(5'→3') | 产物大小/bp |
|---|---|---|
| NLRP3 | 上游:CAAGAATCCACAGTGTAA | 101 |
| 下游:TCTGATTAGTGCTGAGTA | ||
| Caspase-1 | 上游:GAACAAGGAAGAGATGGAGAA 下游:TCGGAATAACGGAGTCAATC | 86 |
| GSDMD | 上游:CTACTGCCTGGTGGTTAG 下游:TTGATAGACAGGTTGACACA | 78 |
| IL-1β | 上游:AATGACCTGAGCACCTTCT 下游:GCACATAAGCCTCGTTATCC | 82 |
| IL-18 | 上游:GACCAAGTTCTCTTCATT 下游:ATAGTTACAGCCATACCT | 143 |
| OPN | 上游:AATGATGAGAGCAATGAG 下游:GTCTACAACCAGCATATC | 114 |
| CD44 | 上游:AACGCAGCAGAGTAATTC 下游:GATGTCAGAGTAGAAGTTGTT | 90 |
| MCP-1 | 上游:CCAGTCACCTGCTGTTAT 下游:GCTTCTTTGGGACACTTG | 98 |
| GAPDH | 上游:TTGCCCTCAACGACCACTTT 下游:TGGTCCAGGGGTCTTACTCC | 120 |
Tab.1 The sequences of primers for qRT-PCR
| 基因名称 | 引物序列(5'→3') | 产物大小/bp |
|---|---|---|
| NLRP3 | 上游:CAAGAATCCACAGTGTAA | 101 |
| 下游:TCTGATTAGTGCTGAGTA | ||
| Caspase-1 | 上游:GAACAAGGAAGAGATGGAGAA 下游:TCGGAATAACGGAGTCAATC | 86 |
| GSDMD | 上游:CTACTGCCTGGTGGTTAG 下游:TTGATAGACAGGTTGACACA | 78 |
| IL-1β | 上游:AATGACCTGAGCACCTTCT 下游:GCACATAAGCCTCGTTATCC | 82 |
| IL-18 | 上游:GACCAAGTTCTCTTCATT 下游:ATAGTTACAGCCATACCT | 143 |
| OPN | 上游:AATGATGAGAGCAATGAG 下游:GTCTACAACCAGCATATC | 114 |
| CD44 | 上游:AACGCAGCAGAGTAATTC 下游:GATGTCAGAGTAGAAGTTGTT | 90 |
| MCP-1 | 上游:CCAGTCACCTGCTGTTAT 下游:GCTTCTTTGGGACACTTG | 98 |
| GAPDH | 上游:TTGCCCTCAACGACCACTTT 下游:TGGTCCAGGGGTCTTACTCC | 120 |
| 组别 | 存活率 | 凋亡率 |
|---|---|---|
| 对照组 | 100.00±2.03 | 2.15±0.83 |
| 0.1 g/L CaCl2组 | 96.96±1.99 | 7.54±2.26 |
| 0.5 g/L CaCl2组 | 95.63±1.37 | 12.89±2.35 |
| 1.0 g/L CaCl2组 | 81.57±3.81a | 17.35±2.28a |
| 2.0 g/L CaCl2组 | 63.14±1.43a | 21.42±1.98a |
| 4.0 g/L CaCl2组 | 46.73±1.15a | 30.82±10.53a |
| 8.0 g/L CaCl2组 | 10.58±0.08a | 39.18±6.74a |
| F | 820.800** | 19.970* |
Tab.2 Comparison of cell survival rate and apoptosis rate between seven groups
| 组别 | 存活率 | 凋亡率 |
|---|---|---|
| 对照组 | 100.00±2.03 | 2.15±0.83 |
| 0.1 g/L CaCl2组 | 96.96±1.99 | 7.54±2.26 |
| 0.5 g/L CaCl2组 | 95.63±1.37 | 12.89±2.35 |
| 1.0 g/L CaCl2组 | 81.57±3.81a | 17.35±2.28a |
| 2.0 g/L CaCl2组 | 63.14±1.43a | 21.42±1.98a |
| 4.0 g/L CaCl2组 | 46.73±1.15a | 30.82±10.53a |
| 8.0 g/L CaCl2组 | 10.58±0.08a | 39.18±6.74a |
| F | 820.800** | 19.970* |
| 组别 | NLRP3 | Caspase-1 | GSDMD | IL-1β | IL-18 | OPN | CD44 | MCP-1 | |
|---|---|---|---|---|---|---|---|---|---|
| 对照组 | 1.01±0.16 | 1.00±0.08 | 1.00±0.03 | 1.00±0.06 | 1.00±0.11 | 1.00±0.04 | 1.01±0.13 | 1.00±0.06 | |
| 1.0 g/L CaCl2组 | 5.42±0.30a | 3.13±0.40a | 1.76±0.25a | 2.14±0.10a | 4.10±0.45a | 74.43±8.66a | 19.42±2.94a | 10.23±1.54a | |
| 2.0 g/L CaCl2组 | 8.24±0.48ab | 4.87±0.57ab | 2.77±0.31ab | 4.63±0.16ab | 5.84±0.73ab | 93.43±5.10ab | 29.24±3.98ab | 15.45±1.83ab | |
| F | 345.700** | 68.850** | 43.350* | 831.300** | 72.350** | 212.900** | 75.530** | 84.250** | |
Tab.3 Comparison of mRNA expression levels between three groups
| 组别 | NLRP3 | Caspase-1 | GSDMD | IL-1β | IL-18 | OPN | CD44 | MCP-1 | |
|---|---|---|---|---|---|---|---|---|---|
| 对照组 | 1.01±0.16 | 1.00±0.08 | 1.00±0.03 | 1.00±0.06 | 1.00±0.11 | 1.00±0.04 | 1.01±0.13 | 1.00±0.06 | |
| 1.0 g/L CaCl2组 | 5.42±0.30a | 3.13±0.40a | 1.76±0.25a | 2.14±0.10a | 4.10±0.45a | 74.43±8.66a | 19.42±2.94a | 10.23±1.54a | |
| 2.0 g/L CaCl2组 | 8.24±0.48ab | 4.87±0.57ab | 2.77±0.31ab | 4.63±0.16ab | 5.84±0.73ab | 93.43±5.10ab | 29.24±3.98ab | 15.45±1.83ab | |
| F | 345.700** | 68.850** | 43.350* | 831.300** | 72.350** | 212.900** | 75.530** | 84.250** | |
| 组别 | NLRP3 | Caspase-1 | GSDMD | OPN | CD44 |
|---|---|---|---|---|---|
| 对照组 | 0.37±0.05 | 0.41±0.04 | 0.51±0.06 | 0.49±0.04 | 0.58±0.05 |
| 1.0 g/L CaCl2组 | 0.79±0.06a | 0.74±0.05a | 0.80±0.05a | 0.96±0.07a | 0.96±0.07a |
| 2.0 g/L CaCl2组 | 1.08±0.06ab | 1.03±0.07ab | 1.04±0.06ab | 1.18±0.04ab | 1.15±0.05ab |
| F | 123.500** | 92.860** | 62.880** | 136.100** | 80.870** |
Tab.4 Comparison of protein expression levels between three groups
| 组别 | NLRP3 | Caspase-1 | GSDMD | OPN | CD44 |
|---|---|---|---|---|---|
| 对照组 | 0.37±0.05 | 0.41±0.04 | 0.51±0.06 | 0.49±0.04 | 0.58±0.05 |
| 1.0 g/L CaCl2组 | 0.79±0.06a | 0.74±0.05a | 0.80±0.05a | 0.96±0.07a | 0.96±0.07a |
| 2.0 g/L CaCl2组 | 1.08±0.06ab | 1.03±0.07ab | 1.04±0.06ab | 1.18±0.04ab | 1.15±0.05ab |
| F | 123.500** | 92.860** | 62.880** | 136.100** | 80.870** |
| 组别 | IL-1β | IL-18 | MCP-1 |
|---|---|---|---|
| 对照组 | 16.13±2.11 | 46.42±3.93 | 203.50±20.85 |
| 1.0 g/L CaCl2组 | 49.32±3.91a | 99.00±5.66a | 423.00±27.30a |
| 2.0 g/L CaCl2组 | 67.95±3.99ab | 121.50±5.63ab | 579.60±44.19ab |
| F | 231.700** | 224.800** | 102.500** |
Tab.5 Comparison of IL-1β, IL-18 and MCP-1 contents in the supernatant of cell culture between three groups
| 组别 | IL-1β | IL-18 | MCP-1 |
|---|---|---|---|
| 对照组 | 16.13±2.11 | 46.42±3.93 | 203.50±20.85 |
| 1.0 g/L CaCl2组 | 49.32±3.91a | 99.00±5.66a | 423.00±27.30a |
| 2.0 g/L CaCl2组 | 67.95±3.99ab | 121.50±5.63ab | 579.60±44.19ab |
| F | 231.700** | 224.800** | 102.500** |
| [1] | FRANK D, VINCE J E. Pyroptosis versus necroptosis: similarities,differences,and crosstalk[J]. Cell Death Differ, 2019, 26(1):99-114. doi:10.1038/s41418-018-0212-6. |
| [2] | JACKSON D N, THEISS A L. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer[J]. Gut Microbes, 2020, 11(3):285-304. doi:10.1080/19490976.2019.1592421. |
| [3] | HUTTON H L, OOI J D, HOLDSWORTH S R, et al. The NLRP3 inflammasome in kidney disease and autoimmunity[J]. Nephrology (Carlton), 2016, 21(9):736-744. doi:10.1111/nep.12785. |
| [4] | LI X, ZENG L, CAO C, et al. Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy[J]. Exp Cell Res, 2017, 350(2):327-335. doi:10.1016/j.yexcr.2016.12.006. |
| [5] | XU G, YUE F, HUANG H, et al. Defects in MAP1S-mediated autophagy turnover of fibronectin cause renal fibrosis[J]. Aging(Albany NY), 2016, 8(5):977-985. doi:10.18632/aging.100957. |
| [6] | HOU J, ZHAO R, XIA W, et al. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis[J]. Nat Cell Biol, 2020, 22(10):1264-1275. doi:10.1038/s41556-020-0575-z. |
| [7] | THONGPRAYOON C, KRAMBECK A E, RULE A D. Determining the true burden of kidney stone disease[J]. Nat Rev Nephrol, 2020, 16(12):736-746. doi:10.1038/s41581-020-0320-7. |
| [8] | THONGBOONKERD V. Proteomics of crystal-cell interactions:a model for kidney stone research[J]. Cells, 2019, 8(9):1076. doi:10.3390/cells8091076. |
| [9] | COE F L, WORCESTER E M, EVAN A P. Idiopathic hypercalciuria and formation of calcium renal stones[J]. Nat Rev Nephrol, 2016, 12(9):519-533. doi:10.1038/nrneph.2016.101. |
| [10] | DAUDON M, HENNEQUIN C, BOUJELBEN G, et al. Serial crystalluria determination and the risk of recurrence in calcium stone formers[J]. Kidney Int, 2005, 67(5):1934-1943. doi:10.1111/j.1523-1755.2005.00292.x. |
| [11] | ANDERS H J, SUAREZ-ALVAREZ B, GRIGORESCU M, et al. The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury[J]. Kidney Int, 2018, 93(3):656-669. doi:10.1016/j.kint.2017.09.022. |
| [12] | KHAN S R, CANALES B K, DOMINGUEZ-GUTIERREZ P R. Randall's plaque and calcium oxalate stone formation:role for immunity and inflammation[J]. Nat Rev Nephrol, 2021, 17(6):417-433. doi:10.1038/s41581-020-00392-1. |
| [13] | RIZVI S H M, PARVEEN A, AHMAD I, et al. Aluminum activates PERK-EIF2α signaling and inflammatory proteins in human neuroblastoma SH-SY5Y cells[J]. Biol Trace Elem Res, 2016, 172(1):108-119. doi:10.1007/s12011-015-0553-7. |
| [14] | KHASKHALI M H, BYER K J, KHAN S R. The effect of calcium on calcium oxalate monohydrate crystal-induced renal epithelial injury[J]. Urol Res, 2009, 37(1):1-6. doi:10.1007/s00240-008-0160-6. |
| [15] | JOSHI S, WANG W, PECK A B, et al. Activation of the NLRP3 inflammasome in association with calcium oxalate crystal induced reactive oxygen species in kidneys[J]. J Urol, 2015, 193(5):1684-1691. doi:10.1016/j.juro.2014.11.093. |
| [16] | LIN Q, LI S, JIANG N, et al. PINK1-parkin pathway of mitophagy protects against contrast-induced acute kidney injury via decreasing mitochondrial ROS and NLRP3 inflammasome activation[J]. Redox Biol, 2019, 26:101254. doi:10.1016/j.redox.2019.101254. |
| [17] | LIU Q, LIU Y, GUAN X, et al. Effect of M2 macrophages on injury and apoptosis of renal tubular epithelial cells induced by calcium oxalate crystals[J]. Kidney Blood Press Res, 2019, 44(4):777-791. doi:10.1159/000501558. |
| [18] | QI S, WANG Q, XIE B, et al. P38 MAPK signaling pathway mediates COM crystal-induced crystal adhesion change in rat renal tubular epithelial cells[J]. Urolithiasis, 2020, 48(1):9-18. doi:10.1007/s00240-019-01143-z. |
| [19] | KHAN S R. Reactive oxygen species,inflammation and calcium oxalate nephrolithiasis[J]. Transl Androl Urol, 2014, 3(3):256-276. doi:10.3978/j.issn.2223-4683.2014.06.04. |
| [20] | QIN B, WANG Q, LU Y, et al. Losartan ameliorates calcium oxalate-induced elevation of stone-related proteins in renal tubular cells by inhibiting NADPH oxidase and oxidative stress[J]. Oxid Med Cell Longev, 2018, 2018:1271864. doi:10.1155/2018/1271864. |
| [21] | ASSELMAN M, VERHULST A, DE BROE M E, et al. Calcium oxalate crystal adherence to hyaluronan-,osteopontin-,and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys[J]. J Am Soc Nephrol, 2003, 14(12):3155-3166. doi:10.1097/01.asn.0000099380.18995.f7. |
| [22] | WANG Z, LI M X, XU C Z, et al. Comprehensive study of altered proteomic landscape in proximal renal tubular epithelial cells in response to calcium oxalate monohydrate crystals[J]. BMC Urol, 2020, 20(1):136. doi:10.1186/s12894-020-00709-z. |
| [1] | ZHOU Yuke, SUN Wei, GAO Qing, HE Jun. The effect of sevoflurane on neuronal inflammation in rats with spinal cord injury by regulating the ROS/TXNIP/NLRP3 pathway [J]. Tianjin Medical Journal, 2025, 53(9): 910-915. |
| [2] | MA Liang, HU Liying, SHI Yu, ZHAO Yongan, SUN Yasi, SUN Guangdong. Analysis of macular retinal thickness characteristics in diabetic kidney disease patients with different blood pressure levels [J]. Tianjin Medical Journal, 2025, 53(9): 923-926. |
| [3] | LIU Haiwei, YANG Jie, WANG Li, MENG Shibo, TANG Xusong, LIU Chengren, WANG Yongwang. Luteolin inhibits glioblastoma by regulating ROS levels via the NFE2L2/x-CT/GPX4 signalling axis [J]. Tianjin Medical Journal, 2025, 53(7): 673-678. |
| [4] | NI Man, GE Jun, KONG Ziang. Correlation analysis of HMGB1 and MCP-1 levels and prognosis of patients with sepsis combined with AKI [J]. Tianjin Medical Journal, 2025, 53(3): 297-301. |
| [5] | HUANG Yeni, DONG Yangzhou, HU Miaoqing, LI Wei, LIU Yang. Effects of Shen 'an decoction on immunity, renal function and lipid metabolism in patients with chronic renal insufficiency [J]. Tianjin Medical Journal, 2025, 53(12): 1309-1314. |
| [6] | ZHENG Xuzhou, LIU Yan, GAO Yufeng, CHEN Rui, ZHANG Xuan. A case of pediatric kidney abscess caused by Bacteroides fragilis [J]. Tianjin Medical Journal, 2025, 53(12): 1330-1333. |
| [7] | GAO Chen, QIAO Yunyang, JI Jialing, WANG E, HUO Ying, ZHANG Aiqing. The effect of bufalin on extracellular matrix synthesis in renal tubular epithelial cells induced by high glucose [J]. Tianjin Medical Journal, 2025, 53(10): 1009-1015. |
| [8] | WU Yameng, LI Liangliang, WANG Yangang, XING Defu. Predictive value of serum APOC1 and Klotho expression for prognosis in patients undergoing laparoscopic partial nephrectomy for renal cancer [J]. Tianjin Medical Journal, 2025, 53(1): 61-64. |
| [9] | SONG Hu, ZHU Jian, FU Yongmei, ZHANG Yongbiao, ZHENG Changlong. The value of combined detection of PCT, IL-6 and CysC for the diagnosis and prognosis assessment of septic acute kidney injury [J]. Tianjin Medical Journal, 2025, 53(1): 65-70. |
| [10] | GAO Pan, XIE Bingxin, ZHOU Zandong, LIU Tong. Promoting effect of circulating FGF23 on atrial fibrosis in chronic kidney disease [J]. Tianjin Medical Journal, 2024, 52(9): 917-923. |
| [11] | LI Yong, SU Yakun, ZHANG Hongbo, LI Yuan, LI Zhanhu, YAN Xiaoju. Clinical significance of serum asprosin level in patients with early renal damage of essential hypertension [J]. Tianjin Medical Journal, 2024, 52(6): 609-613. |
| [12] | CHU Jiyan, TIAN Jing, FU Diyu, GUO Lin, SUN Rui, LI Ping. Expression and significance of AIM2 inflammasome in patients with acute gouty arthritis [J]. Tianjin Medical Journal, 2024, 52(5): 518-522. |
| [13] | WANG Yue, QUAN Xingmiao, WANG Yu, SONG Chunxia, SHAO Yue, XU Liwei. Influence of Yiqi Shengqing recipe on neuron pyroptosis in ischemic stroke rats by regulating HIF-1α/NLRP3 signal pathway [J]. Tianjin Medical Journal, 2024, 52(4): 350-355. |
| [14] | FAN Hui, MA Yu, LI Ximing. Research progress in the prevention of contrast-related acute kidney injury [J]. Tianjin Medical Journal, 2024, 52(3): 327-330. |
| [15] | YI Na, XIAO Wen, TIAN Yuan, YUAN Lili. Mechanism of BMAL1 attenuating H2O2-induced cardiomyocyte injury [J]. Tianjin Medical Journal, 2024, 52(2): 119-123. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||